| Literature DB >> 33782885 |
Parisa Mortaji1, Dale Terasaki2,3, Jaime Moo-Young2,4.
Abstract
Opioid use disorder has affected many lives across the US. Medications for opioid use disorder (MOUD), including buprenorphine, have been shown to decrease mortality in this patient population. Here we present a case of a 32-year-old woman on buprenorphine/naloxone undergoing multiple surgical operations, whose course included buprenorphine discontinuation, methadone initiation, and buprenorphine re-induction using a novel "microdosing" approach. This report includes a presentation of the case and a discussion of the clinical decision making and relevant literature to give hospitalbased providers a perspective on management of peri-operative patients on MOUD.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33782885 PMCID: PMC8342648 DOI: 10.1007/s11606-021-06739-z
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 6.473